Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Neuroprotection in Huntington's disease: a 2-year study on minocycline.
Potentiation of High Voltage-Activated Calcium Channels by 4-Aminopyridine Depends upon Subunit Composition.
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.
ACUTE RETINAL NECROSIS AND IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN A NATALIZUMAB-TREATED PATIENT WITH MULTIPLE SCLEROSIS.
Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs.
Multiple sclerosis and glutamate excitotoxicity.
Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
The Implication of Vitamin D and Autoimmunity: a Comprehensive Review.
The role of microglial activation in disease progression.
Navigating Life and Loss in Pediatric Multiple Sclerosis.
Purkinje cell pathology and loss in multiple sclerosis cerebellum.
Natalizumab discontinuation and disease restart in pregnancy: a case series.
Bioinformatics challenges for genome-wide association studies.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.
Value of NMO-IgG determination at the time of presentation as CIS.
Proceedings of the European Charcot Foundation Symposium A Reappraisal of Nutrition and Environment in Multiple Sclerosis, European Charcot Foundation Symposium, December 2-4, 2010, Fiuggi, Italy.
Compressive syndrome of internal jugular veins in multiple sclerosis: does it matter?
Brain imaging and bladder function.

Pages